MetaADEDB 2.0 @ LMMD
Irinotecan
(GURKHSYORGJETM-WAQYZQTGSA-N)
Structure
SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1c3nc4ccc(cc4c(c3Cn1c2=O)CC)OC(=O)N1CCC(CC1)N1CCCCC1.Cl
Molecular Formula:
C33H39ClN4O6
Molecular Weight:
623.139
Log P:
4.7689
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
2
TPSA:
114.2
CAS Number(s):
100286-90-6
Synonym(s)
1.
Irinotecan
2.
7-Ethyl-10-hydroxycamptothecin
3.
CPT 11
4.
CPT-11
5.
Camptosar
6.
Camptothecin-11
7.
Irinotecan Hydrochloride
8.
Irrinotecan
9.
NK012 Compound
10.
SN 38
11.
SN 38 11
12.
SN-38
13.
SN-38-11
14.
7 Ethyl 10 hydroxycamptothecin
15.
CPT11
16.
Camptothecin 11
17.
SN3811
External Link(s)
MeSHD000077146
PubChem Compound74990
67108483
ChEBI5971
CHEMBLCHEMBL541887
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NeutropeniaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
2DehydrationFAERS: 14US FAERS
3VomitingFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
4Febrile NeutropeniaFAERS: 13US FAERS
5NauseaFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
6Abdominal PainFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
7DysarthriaFAERS: 10US FAERS
8PneumonitisFAERS: 8US FAERS
9AphasiaFAERS: 7US FAERS
10DizzinessFAERS: 7US FAERS
11ThrombocytopeniaFAERS: 7US FAERS
12ChillsFAERS: 6US FAERS
13Infection reactivationFAERS: 6US FAERS
14LeukopeniaFAERS: 6US FAERS
15PneumoniaFAERS: 6US FAERS
16Toxicity to various agentsFAERS: 6
Canada Vigilance: 6
Canada Vigilance
US FAERS
17Disease ProgressionFAERS: 5US FAERS
18ErythemaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
19FatigueFAERS: 5US FAERS
20General physical health deteriorationFAERS: 5US FAERS
21PruritusFAERS: 5US FAERS
22Respiratory FailureFAERS: 5US FAERS
23Septic ShockFAERS: 5US FAERS
24AstheniaFAERS: 4US FAERS
25Chest PainFAERS: 4US FAERS
26EmpyemaFAERS: 4US FAERS
27FlushingFAERS: 4US FAERS
28MYELODYSPLASTIC SYNDROMEFAERS: 4US FAERS
29SepsisFAERS: 4US FAERS
30UrticariaFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
31AlopeciaFAERS: 3US FAERS
32CholangitisFAERS: 3US FAERS
33HypotensionFAERS: 3US FAERS
34Large intestine perforationFAERS: 3US FAERS
35LymphopeniaFAERS: 3US FAERS
36MalaiseFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Malignant neoplasm progressionFAERS: 3US FAERS
38Neutropenic sepsisFAERS: 3US FAERS
39PneumothoraxFAERS: 3US FAERS
40ShockFAERS: 3US FAERS
41White blood cell count decreasedFAERS: 3US FAERS
42Acute kidney injuryFAERS: 2US FAERS
43Alanine Aminotransferase IncreasedFAERS: 2US FAERS
44AngioedemaFAERS: 2US FAERS
45AnorexiaFAERS: 2US FAERS
46Blood creatinine increasedFAERS: 2US FAERS
47Blood iron increasedFAERS: 2US FAERS
48Blood magnesium decreasedFAERS: 2US FAERS
49Blood urea increasedFAERS: 2US FAERS
50Cold sweatFAERS: 2US FAERS
51Disseminated Intravascular CoagulationFAERS: 2US FAERS
52DyspepsiaFAERS: 2US FAERS
53Gastrointestinal toxicityFAERS: 2US FAERS
54HemiparesisFAERS: 2US FAERS
55HyperpyrexiaFAERS: 2US FAERS
56HypersensitivityFAERS: 2US FAERS
57Ileal ulcerFAERS: 2US FAERS
58LeukocytosisFAERS: 2US FAERS
59Metabolic acidosisFAERS: 2US FAERS
60MyoclonusFAERS: 2US FAERS
61Neutropenic colitisFAERS: 2US FAERS
62Oral mucosal exfoliationFAERS: 2US FAERS
63PancytopeniaFAERS: 2US FAERS
64PolyneuropathyFAERS: 2US FAERS
65Post procedural bile leakFAERS: 2US FAERS
66Pulmonary toxicityFAERS: 2US FAERS
67RalesFAERS: 2US FAERS
68Renal tubular acidosisFAERS: 2US FAERS
69Sudden deathFAERS: 2US FAERS
70SyncopeFAERS: 2US FAERS
71TachycardiaFAERS: 2US FAERS
72WheezingFAERS: 2US FAERS
73Abdominal AbscessFAERS: 1US FAERS
74AbscessFAERS: 1US FAERS
75AcidosisFAERS: 1US FAERS
76Acute Coronary SyndromeFAERS: 1US FAERS
77Acute myocardial infarctionFAERS: 1US FAERS
78Anal infectionFAERS: 1US FAERS
79Anaphylactic shockFAERS: 1US FAERS
80Angina PectorisFAERS: 1US FAERS
81Anti-platelet antibody positiveFAERS: 1US FAERS
82AscitesFAERS: 1US FAERS
83Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
84AsthmaFAERS: 1US FAERS
85Autonomic neuropathyFAERS: 1US FAERS
86Back PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Bacteria blood identifiedFAERS: 1US FAERS
88Blood bilirubin unconjugated increasedFAERS: 1US FAERS
89Blood creatine increasedFAERS: 1US FAERS
90Blood creatinine decreasedFAERS: 1US FAERS
91Blood potassium decreasedFAERS: 1US FAERS
92Blood pressure inadequately controlledFAERS: 1US FAERS
93Blood pressure orthostatic abnormalFAERS: 1US FAERS
94Blood sodium decreasedFAERS: 1US FAERS
95BradycardiaFAERS: 1US FAERS
96Bronchopulmonary AspergillosisFAERS: 1US FAERS
97Carbohydrate antigen 19-9 increasedFAERS: 1US FAERS
98CellulitisFAERS: 1US FAERS
99Cerebral InfarctionFAERS: 1US FAERS
100Cerebral ThrombosisFAERS: 1US FAERS
101Cerebrovascular accidentFAERS: 1US FAERS
102Chest discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
103ColitisFAERS: 1US FAERS
104ConstipationFAERS: 1US FAERS
105Coronary Artery DiseaseFAERS: 1US FAERS
106Device related infectionFAERS: 1US FAERS
107Diabetes MellitusFAERS: 1US FAERS
108DiplopiaFAERS: 1US FAERS
109Drug abuserFAERS: 1US FAERS
110Drug ineffectiveFAERS: 1US FAERS
111Drug toxicityFAERS: 1US FAERS
112Drug withdrawal syndromeFAERS: 1US FAERS
113Duodenal ulcer perforationFAERS: 1US FAERS
114DyslaliaFAERS: 1US FAERS
115DysuriaFAERS: 1US FAERS
116Electrocardiogram abnormalFAERS: 1US FAERS
117EpilepsyFAERS: 1US FAERS
118EructationFAERS: 1US FAERS
119Essential HypertensionFAERS: 1US FAERS
120ExtravasationFAERS: 1US FAERS
121Eye irritationFAERS: 1US FAERS
122Fanconi SyndromeFAERS: 1US FAERS
123Fine motor delayFAERS: 1US FAERS
124FlatulenceFAERS: 1US FAERS
125Gastric infectionFAERS: 1US FAERS
126Gastrointestinal candidiasisFAERS: 1US FAERS
127Gene MutationFAERS: 1US FAERS
128Gram stain positiveFAERS: 1US FAERS
129HeadacheFAERS: 1US FAERS
130HepatitisFAERS: 1US FAERS
131HepatomegalyFAERS: 1US FAERS
132HomicideFAERS: 1US FAERS
133HypertransaminasaemiaFAERS: 1US FAERS
134IncontinenceFAERS: 1US FAERS
135Incorrect route of drug administrationFAERS: 1US FAERS
136Infusion site swellingFAERS: 1US FAERS
137LaryngospasmFAERS: 1US FAERS
138LeukoencephalopathyFAERS: 1US FAERS
139Lip swellingFAERS: 1US FAERS
140Liver AbscessFAERS: 1US FAERS
141MacroglossiaFAERS: 1US FAERS
142MalnutritionFAERS: 1US FAERS
143MetastasisFAERS: 1US FAERS
144Monocyte count decreasedFAERS: 1US FAERS
145MyalgiaFAERS: 1US FAERS
146MyocarditisFAERS: 1US FAERS
147MyositisFAERS: 1US FAERS
148NeuropathyFAERS: 1US FAERS
149Oculomucocutaneous syndromeFAERS: 1US FAERS
150Oropharyngeal painFAERS: 1US FAERS
151PainFAERS: 1US FAERS
152Pelvic abscessFAERS: 1US FAERS
153Performance status decreasedFAERS: 1US FAERS
154Pericardial effusionFAERS: 1US FAERS
155Peripheral motor neuropathyFAERS: 1US FAERS
156PeritonitisFAERS: 1US FAERS
157PetechiaeFAERS: 1US FAERS
158PhlebitisFAERS: 1US FAERS
159Pleural InfectionFAERS: 1US FAERS
160Pneumatosis intestinalisFAERS: 1US FAERS
161Portal venous gasFAERS: 1US FAERS
162Product barcode issueFAERS: 1US FAERS
163Product quality issueFAERS: 1US FAERS
164Productive CoughFAERS: 1US FAERS
165Pseudomonas bronchitisFAERS: 1US FAERS
166Pulmonary EmbolismFAERS: 1US FAERS
167Pulmonary FibrosisFAERS: 1US FAERS
168PurulenceFAERS: 1US FAERS
169Recall phenomenonFAERS: 1US FAERS
170Sense of oppressionFAERS: 1US FAERS
171Small cell lung cancer extensive stageFAERS: 1US FAERS
172Small intestinal ulcer perforationFAERS: 1US FAERS
173StomatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
174SubileusFAERS: 1US FAERS
175Sudden Visual LossFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
176SwellingFAERS: 1US FAERS
177TachyphylaxisFAERS: 1US FAERS
178Therapy non-responderFAERS: 1US FAERS
179Transaminases increasedFAERS: 1US FAERS
180Transferrin saturation increasedFAERS: 1US FAERS
181TremorFAERS: 1US FAERS
182VasculitisFAERS: 1US FAERS
183pseudomembranous colitisFAERS: 1US FAERS
184Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.